Literature DB >> 16633825

Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment.

Waldemar Narozny1, Jerzy Kuczkowski, Czeslaw Stankiewicz, Jacek Kot, Boguslaw Mikaszewski, Tomasz Przewozny.   

Abstract

Malignant external otitis (MEO) is an invasive, morbidity, even mortality, mainly pseudomonal infection of the external auditory canal, frequently involving the base of the skull, multiple cranial nerve and the meninges. In many cases conventional therapy has been prolonged, intensive and relatively ineffective, especially in infections other than bacterial (mainly fungal). We presented theoretical principles of hyperbaric oxygen (HBO) treatment in MEO, our own experience and others' experience in applying this treatment method. We treated eight patients with MEO applying pharmacotherapy, topical management, surgery in one case and also adjunct HBO. In six patients, infection was caused by Pseudomonas aeruginosa, in one by Staphylococcus sp. and in one by Aspergillus sp. Complete recovery was achieved in seven patients. In the patient with MEO caused by Aspergillus sp., intracranial complications developed and the patient died. Our experiences in employing HBO in bacterial-caused MEO have confirmed the role of HBO as a valuable, beneficial, supporting classical treatment method. Small number of patients with MEO, especially with non-bacterial infection, and unforeseen clinical course of disease make our experience difficult to objectivize.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633825     DOI: 10.1007/s00405-006-0033-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Otogenic skull base osteomyelitis caused by invasive fungal infection.

Authors:  M R Menachof; R K Jackler
Journal:  Otolaryngol Head Neck Surg       Date:  1990-03       Impact factor: 3.497

2.  Adjuvant hyperbaric oxygen in malignant external otitis.

Authors:  J C Davis; G A Gates; C Lerner; M G Davis; J T Mader; A Dinesman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-01

3.  [The treatment of necrotizing otitis externa with a combination of surgery, antibiotics, specific immunoglobulins and hyperbaric oxygen therapy. Results of the Ulm Treatment Concept].

Authors:  M Tisch; K J Lorenz; M Harm; L Lampl; H Maier
Journal:  HNO       Date:  2003-04       Impact factor: 1.284

Review 4.  Fungal malignant otitis externa due to Scedosporium apiospermum.

Authors:  M Yao; A H Messner
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-04       Impact factor: 1.547

5.  Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up.

Authors:  J R Grandis; H D Curtin; V L Yu
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

6.  Malignant external otitis. Cure with adjunctive hyperbaric oxygen therapy.

Authors:  J T Mader; J T Love
Journal:  Arch Otolaryngol       Date:  1982-01

7.  Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient.

Authors:  Gal Finer; David Greenberg; Eugene Leibovitz; Alberto Leiberman; Ilan Shelef; Joseph Kapelushnik
Journal:  Scand J Infect Dis       Date:  2002

8.  Alteration of effectiveness of antibiotics by anaerobiosis.

Authors:  R M Verklin; G L Mandell
Journal:  J Lab Clin Med       Date:  1977-01

9.  Necrotizing (malignant) external otitis.

Authors:  Ophir Handzel; Doron Halperin
Journal:  Am Fam Physician       Date:  2003-07-15       Impact factor: 3.292

10.  Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.

Authors:  Leonard Berenholz; Udi Katzenell; Moshe Harell
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

View more
  14 in total

1.  Malignant external otitis with extensive cranial neuropathy but no facial paralysis.

Authors:  Daniel Kondziella; Ina Skagervik
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

2.  Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre.

Authors:  Carla Espiney Amaro; Raquel Espiney; Lucian Radu; Francisco Guerreiro
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-04       Impact factor: 2.503

Review 3.  Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.

Authors:  Perrine Parize; Marie-Olivia Chandesris; Fanny Lanternier; Sylvain Poirée; Jean-Paul Viard; Boris Bienvenu; Michaël Mimoun; Frédéric Méchai; Marie-France Mamzer; Philippe Herman; Marie-Elisabeth Bougnoux; Marc Lecuit; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

4.  The significance of tissue biopsy for fungi in necrotizing otitis externa.

Authors:  Rani Abu Eta; Haim Gavriel; Kleid Stephen; Ephraim Eviatar; Eyal Yeheskeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-05       Impact factor: 2.503

5.  Malignant Otitis Externa: A Retrospective Analysis and Treatment Outcomes.

Authors:  İsa Kaya; Baha Sezgin; Sevinç Eraslan; Kerem Öztürk; Sercan Göde; Cem Bilgen; Tayfun Kirazlı
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

6.  Indications for surgery in necrotizing otitis externa.

Authors:  Jerzy Kuczkowski; Tomasz K Nowicki
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-01       Impact factor: 2.503

7.  Malignant otitis externa with skull base osteomyelitis.

Authors:  E Illing; M Zolotar; E Ross; O Olaleye; N Molony
Journal:  J Surg Case Rep       Date:  2011-05-01

8.  Research of medical gases in Poland.

Authors:  Robert P Ostrowski; Emanuela B Pucko
Journal:  Med Gas Res       Date:  2013-08-02

9.  Fungal malignant otitis externa with facial nerve palsy: tissue biopsy AIDS diagnosis.

Authors:  Jenny Walton; Chris Coulson
Journal:  Case Rep Otolaryngol       Date:  2014-02-05

10.  Temporomandibular joint disorder from skull-base osteomyelitis: a case report.

Authors:  Suck-Chul Lee; Jae-Hyung Kim; Chul-Hoon Kim; Bok-Joo Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.